Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROS-1: Male Hormonal Contraceptive Regimens and Prostate Tissue
NCT00490555Phase 3Completed
- Sponsor
- University of Washington
- Start
- Jan 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Testosterone TEPI patch, dutasteride and medroxyprogesterone acetate in contraception (4 arms), sponsored by University of Washington. Primary endpoints: Prostate-specific Antigen at 10 weeks, Testosterone Concentration at 10 weeks and 1 more. Started Jan 2009; status: completed.
02
Drugs
Testosterone TEPI patchdutasteridemedroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00490555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490555.